Strategies toward rheumatoid arthritis therapy; the old and the new

M Abbasi, MJ Mousavi, S Jamalzehi… - Journal of cellular …, 2019 - Wiley Online Library
Currently, medications used to treat rheumatoid arthritis (RA) are glucocorticoids (GCs) and
nonsteroidal anti‐inflammatory drugs (NSAIDs), predominantly used for controlling the pain …

[HTML][HTML] New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics

SY Pan, SF Zhou, SH Gao, ZL Yu, SF Zhang… - Evidence-based …, 2013 - hindawi.com
With tens of thousands of plant species on earth, we are endowed with an enormous wealth
of medicinal remedies from Mother Nature. Natural products and their derivatives represent …

Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial

SR Kahn, S Shapiro, PS Wells, MA Rodger, MJ Kovacs… - The Lancet, 2014 - thelancet.com
Background Post-thrombotic syndrome (PTS) is a common and burdensome complication of
deep venous thrombosis (DVT). Previous trials suggesting benefit of elastic compression …

Glucosamine therapy for treating osteoarthritis

T Towheed, L Maxwell… - Cochrane database …, 2005 - cochranelibrary.com
Background Osteoarthritis (OA) is a common form of arthritis and is often associated with
significant disability and impaired quality of life. This is an update of a Cochrane review first …

[HTML][HTML] Non-steroidal anti-inflammatory drugs: Recent advances in the use of synthetic COX-2 inhibitors

M Ahmadi, S Bekeschus, KD Weltmann… - RSC Medicinal …, 2022 - pubs.rsc.org
Cyclooxygenase (COX) enzymes comprise COX-1 and COX-2 isoforms and are responsible
for prostaglandin production. Prostaglandins have critical roles in the inflammation pathway …

[HTML][HTML] Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review

G Varrassi, JV Pergolizzi, P Dowling, A Paladini - Advances in therapy, 2020 - Springer
Ibuprofen first came to market about 50 years ago and rapidly moved to over-the-counter
(OTC) sales. In April 2019, the National Agency for the Safety of Medicines and Health …

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome

JVA Franco, T Turk, JH Jung, YT Xiao… - Cochrane Database …, 2019 - cochranelibrary.com
Background Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common
disorder in which the two main clinical features are pelvic pain and lower urinary tract …

[HTML][HTML] Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: A bioinformatics approach

RP Leão, JV Cruz, GV da Costa, JN Cruz… - Pharmaceuticals, 2020 - mdpi.com
The cyclooxygenase-2 receptor is a therapeutic target for planning potential drugs with anti-
inflammatory activity. The selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib was …

Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR

MA Meshram, UO Bhise, PN Makhal, VR Kaki - European Journal of …, 2021 - Elsevier
Inflammation is a most complex pathological process that gives birth to different diseases.
Different inflammatory mediators are released during an inflammation responsible for acute …

Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies

AM Alfayomy, SA Abdel-Aziz, AA Marzouk… - Bioorganic …, 2021 - Elsevier
Abstract Two new series of 1, 3, 4-oxadiazole and coumarin derivatives based on pyrimidine-
5-carbonitrile scaffold have been synthesized and evaluated for their COX-1/COX-2 …